Eun Hye Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Eun Hye Kim has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ho Yun Lee
Department of Otorhinolaryngology-Head and Neck Surgery, Ewha Womans University School of Medicine, Seoul, Republic of Korea
2 shared publications - Seung-Ho Shin
Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Ewha Womans University, Seoul, Korea
2 shared publications - Sung Wan Byun
Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Ewha Womans University, Seoul, Korea
2 shared publications - Min Woo Kim
Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
1 shared publication - Min-Jee Kim
Department of Biochemistry and Molecular Biology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea
1 shared publication - Sohl Park
Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Ewha Womans University, Seoul, Korea
1 shared publication
Latest Publications
- Open Access
- 31 August 2026
- Published by Korean Society of Laryngology, Phoniatrics and Logopedics in Journal of The Korean Society of Laryngology, Phoniatrics and Logopedics
- Vol. 37 (2) , 108-112
Herpes Zoster Laryngitis Presenting as Unilateral Vocal Fold Paralysis With Delayed Facial Palsy: A Case Report
Herpes zoster laryngitis (HZL) is a rare manifestation of varicella-zoster virus (VZV) infection involving the larynx. It typically presents with sore throat, odynophagia, hoarseness, and unilateral vesicular or ulcerative mucosal lesions. Because of its rarity and nonspecific clinical manifestations, HZL is frequently misdiagnosed as viral laryngopharyngitis, laryngeal malignancy, or Ramsay Hunt syndrome. A 66-year-old woman presented with hoarseness and unilateral vocal fold paralysis accompanied by ipsilateral arytenoid swelling and an ulcerative laryngeal lesion. The lesion was initially suspected to represent laryngeal malignancy, and a biopsy was performed. Histopathological examination confirmed herpetic infection consistent with HZL. Approximately 2 weeks after the initial presentation, the patient developed delayed-onset House-Brackmann Grade III facial nerve palsy. Following treatment with systemic antiviral agents and corticosteroids, both the laryngeal lesion and facial palsy gradually improved. HZL should be considered in patients presenting with unilateral vocal fold paralysis and ulcerative laryngeal lesions, even in the absence of facial nerve involvement at initial presentation. Delayed facial palsy may occur during the disease course, highlighting the importance of early recognition, pathological confirmation when indicated, and prompt antiviral treatment.
- 31 August 2026
- Published by Korean Society of Laryngology, Phoniatrics and Logopedics in Journal of The Korean Society of Laryngology, Phoniatrics and Logopedics
- Vol. 37 (2) , 108-112
Open AccessHerpes Zoster Laryngitis Presenting as Unilateral Vocal Fold Paralysis With Delayed Facial Palsy: A Case Report
Herpes zoster laryngitis (HZL) is a rare manifestation of varicella-zoster virus (VZV) infection involving the larynx. It typically presents with sore throat, odynophagia, hoarseness, and unilateral vesicular or ulcerative mucosal lesions. Because of its rarity and nonspecific clinical manifestations, HZL is frequently misdiagnosed as viral laryngopharyngitis, laryngeal malignancy, or Ramsay Hunt syndrome. A 66-year-old woman presented with hoarseness and unilateral vocal fold paralysis accompanied by ipsilateral arytenoid swelling and an ulcerative laryngeal lesion. The lesion was initially suspected to represent laryngeal malignancy, and a biopsy was performed. Histopathological examination confirmed herpetic infection consistent with HZL. Approximately 2 weeks after the initial presentation, the patient developed delayed-onset House-Brackmann Grade III facial nerve palsy. Following treatment with systemic antiviral agents and corticosteroids, both the laryngeal lesion and facial palsy gradually improved. HZL should be considered in patients presenting with unilateral vocal fold paralysis and ulcerative laryngeal lesions, even in the absence of facial nerve involvement at initial presentation. Delayed facial palsy may occur during the disease course, highlighting the importance of early recognition, pathological confirmation when indicated, and prompt antiviral treatment.
- Open Access
- 29 September 2022
- Published by XMLink in Yonsei Medical Journal
- Vol. 63 (11) , 1035-1042
Clinical Findings That Differentiate Co-Occurrence of Hyperacusis and Tinnitus from Tinnitus Alone
Shin SH, et al. Yonsei Med J. 2022 Nov;63(11):1035-1042. https://doi.org/10.3349/ymj.2022.0274
- 29 September 2022
- Published by XMLink in Yonsei Medical Journal
- Vol. 63 (11) , 1035-1042
Open AccessClinical Findings That Differentiate Co-Occurrence of Hyperacusis and Tinnitus from Tinnitus Alone
Shin SH, et al. Yonsei Med J. 2022 Nov;63(11):1035-1042. https://doi.org/10.3349/ymj.2022.0274
- Open Access
- 10 October 2021
- Published by The Korean Audiological Society in Journal of Audiology and Otology
- Vol. 25 (4) , 209-216
Optimal First-Line Therapy for Acute Low-Tone Sensorineural Hearing Loss
Background and Objectives: We aimed to analyze treatment outcomes following different initial management approaches and confirm treatment regimens for acute low-tone sensorineural hearing loss (ALHL) that would yield the best results.Subjects and Methods: We retrospectively analyzed the medical records of 106 patients with ALHL who visited a university hospital’s otology clinic from March 2013 to June 2019. Pure-tone averages at the initial visit and at 2 and 4 weeks after the initial visit were evaluated.Results: Forty-nine patients were enrolled in this study; of them, 41 (83.7%) exhibited complete recovery (CR) at 2 weeks and 43 (87.8%) exhibited CR at 1 month after the initial visit. Regression analysis revealed that CR at 2 weeks after the initial visit was associated with diuretic use [Exp(B): 10.309, 95% confidence interval (CI): 1.007-100]. An initial daily low-dose steroid use was marginally significant [Exp(B): 1.042, 95% CI: 0.997-1.092; p=0.066]. Isolated diuretic use [Exp(B): 25.641, 95% CI: 1.121-90.909; p=0.039] was an independent, good prognostic factor at 1 month after the initial visit. However, other treatment regimens did not affect the final results.Conclusions: A combination of initial daily administration of ≤30 mg prednisolone plus diuretics was sufficient as the first-line treatment for ALHL. High-dose steroids and salvage intratympanic steroid injections can be applied as a second choice; however, the predicted outcome would not be good in that case.
- 10 October 2021
- Published by The Korean Audiological Society in Journal of Audiology and Otology
- Vol. 25 (4) , 209-216
Open AccessOptimal First-Line Therapy for Acute Low-Tone Sensorineural Hearing Loss
Background and Objectives: We aimed to analyze treatment outcomes following different initial management approaches and confirm treatment regimens for acute low-tone sensorineural hearing loss (ALHL) that would yield the best results.Subjects and Methods: We retrospectively analyzed the medical records of 106 patients with ALHL who visited a university hospital’s otology clinic from March 2013 to June 2019. Pure-tone averages at the initial visit and at 2 and 4 weeks after the initial visit were evaluated.Results: Forty-nine patients were enrolled in this study; of them, 41 (83.7%) exhibited complete recovery (CR) at 2 weeks and 43 (87.8%) exhibited CR at 1 month after the initial visit. Regression analysis revealed that CR at 2 weeks after the initial visit was associated with diuretic use [Exp(B): 10.309, 95% confidence interval (CI): 1.007-100]. An initial daily low-dose steroid use was marginally significant [Exp(B): 1.042, 95% CI: 0.997-1.092; p=0.066]. Isolated diuretic use [Exp(B): 25.641, 95% CI: 1.121-90.909; p=0.039] was an independent, good prognostic factor at 1 month after the initial visit. However, other treatment regimens did not affect the final results.Conclusions: A combination of initial daily administration of ≤30 mg prednisolone plus diuretics was sufficient as the first-line treatment for ALHL. High-dose steroids and salvage intratympanic steroid injections can be applied as a second choice; however, the predicted outcome would not be good in that case.